Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment

The prevalence of cerebrovascular disease increases with age, placing the elderly at a greater lifetime risk for dementia. Vascular cognitive impairment (VCI) encompasses a spectrum of cognitive deficits from mild cognitive impairment to dementia. VCI and its most severe form, vascular dementia (VaD...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Theranostics 2022-01, Vol.12 (4), p.1639-1658
Hauptverfasser: Rajeev, Vismitha, Fann, David Y, Dinh, Quynh Nhu, Kim, Hyun Ah, De Silva, T Michael, Lai, Mitchell K P, Chen, Christopher Li-Hsian, Drummond, Grant R, Sobey, Christopher G, Arumugam, Thiruma V
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1658
container_issue 4
container_start_page 1639
container_title Theranostics
container_volume 12
creator Rajeev, Vismitha
Fann, David Y
Dinh, Quynh Nhu
Kim, Hyun Ah
De Silva, T Michael
Lai, Mitchell K P
Chen, Christopher Li-Hsian
Drummond, Grant R
Sobey, Christopher G
Arumugam, Thiruma V
description The prevalence of cerebrovascular disease increases with age, placing the elderly at a greater lifetime risk for dementia. Vascular cognitive impairment (VCI) encompasses a spectrum of cognitive deficits from mild cognitive impairment to dementia. VCI and its most severe form, vascular dementia (VaD), is becoming a major public health concern worldwide. As growing efforts are being taken to understand VCI and VaD in animal models and humans, the pathogenesis of the disease is being actively explored. It is postulated that chronic cerebral hypoperfusion (CCH) is a major cause of VCI. CCH activates a molecular and cellular injury cascade that leads to breakdown of the blood brain barrier (BBB) and neurodegeneration. The BBB tightly regulates the movement of substances between the blood and the brain, thereby regulating the microenvironment within the brain parenchyma. Here we illustrate how BBB damage is causal in the pathogenesis of VCI through the increased activation of pathways related to excitotoxicity, oxidative stress, inflammation and matrix metalloproteinases that lead to downstream perivascular damage, leukocyte infiltration and white matter changes in the brain. Thus, CCH-induced BBB damage may initiate and contribute to a vicious cycle, resulting in progressive neuropathological changes of VCI in the brain. This review outlines the molecular and cellular mechanisms that govern BBB breakdown during CCH and highlights the clinical evidence in identifying at-risk VCI patients.
doi_str_mv 10.7150/thno.68304
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8825579</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2632804397</sourcerecordid><originalsourceid>FETCH-LOGICAL-c406t-b9e174d7f7b46e7027ec226bc23e63c747ba12b4ca2e54671669fa87889e32bd3</originalsourceid><addsrcrecordid>eNpdkUtr3TAQhUVpaUKaTX9AEXRTCjfRy5K8KZTQFwSSRboWkjy-VrAlV7Iv-N9Xt0lDWm1GMN-cOcNB6C0lF4o25HIZYrqQmhPxAp1SzfVOSUFePvufoPNS7kl9grCWtq_RCW9oq4lkp2i7tcuQ5mErIY1pv-HUYzem1GGXbYjY2ZwDZNxtpV-jX0KKuFtziHvsh5xi8NhDhgqPeNjmNEPu13Kk6vDBFr-ONmOf9jEs4QA4TLMNeYK4vEGvejsWOH-sZ-jn1y93V9931zffflx9vt55QeSycy1QJTrVKyckKMIUeMak84yD5F4J5SxlTnjLoBFSUSnb3mqldQucuY6foU8PuvPqJuh8XV3NmjmHyebNJBvMv50YBrNPB6M1axrVVoEPjwI5_VqhLGYKxcM42ghpLYZJzjQRvFUVff8fep_WHOt5hilJtBS0oZX6-ED5nErJ0D-ZocQcQzXHUM2fUCv87rn9J_RvhPw3kV-hNg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2760864151</pqid></control><display><type>article</type><title>Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Rajeev, Vismitha ; Fann, David Y ; Dinh, Quynh Nhu ; Kim, Hyun Ah ; De Silva, T Michael ; Lai, Mitchell K P ; Chen, Christopher Li-Hsian ; Drummond, Grant R ; Sobey, Christopher G ; Arumugam, Thiruma V</creator><creatorcontrib>Rajeev, Vismitha ; Fann, David Y ; Dinh, Quynh Nhu ; Kim, Hyun Ah ; De Silva, T Michael ; Lai, Mitchell K P ; Chen, Christopher Li-Hsian ; Drummond, Grant R ; Sobey, Christopher G ; Arumugam, Thiruma V</creatorcontrib><description>The prevalence of cerebrovascular disease increases with age, placing the elderly at a greater lifetime risk for dementia. Vascular cognitive impairment (VCI) encompasses a spectrum of cognitive deficits from mild cognitive impairment to dementia. VCI and its most severe form, vascular dementia (VaD), is becoming a major public health concern worldwide. As growing efforts are being taken to understand VCI and VaD in animal models and humans, the pathogenesis of the disease is being actively explored. It is postulated that chronic cerebral hypoperfusion (CCH) is a major cause of VCI. CCH activates a molecular and cellular injury cascade that leads to breakdown of the blood brain barrier (BBB) and neurodegeneration. The BBB tightly regulates the movement of substances between the blood and the brain, thereby regulating the microenvironment within the brain parenchyma. Here we illustrate how BBB damage is causal in the pathogenesis of VCI through the increased activation of pathways related to excitotoxicity, oxidative stress, inflammation and matrix metalloproteinases that lead to downstream perivascular damage, leukocyte infiltration and white matter changes in the brain. Thus, CCH-induced BBB damage may initiate and contribute to a vicious cycle, resulting in progressive neuropathological changes of VCI in the brain. This review outlines the molecular and cellular mechanisms that govern BBB breakdown during CCH and highlights the clinical evidence in identifying at-risk VCI patients.</description><identifier>ISSN: 1838-7640</identifier><identifier>EISSN: 1838-7640</identifier><identifier>DOI: 10.7150/thno.68304</identifier><identifier>PMID: 35198062</identifier><language>eng</language><publisher>Australia: Ivyspring International Publisher Pty Ltd</publisher><subject>Age ; Aged ; Alzheimer's disease ; Animals ; Blood vessels ; Blood-brain barrier ; Blood-Brain Barrier - metabolism ; Brain - metabolism ; Brain Ischemia - pathology ; Cardiovascular disease ; Cognitive ability ; Cognitive Dysfunction - metabolism ; Dementia ; Dementia, Vascular - etiology ; Dementia, Vascular - metabolism ; Humans ; Measurement techniques ; Metabolism ; Pathology ; Pathophysiology ; Permeability ; Physiology ; Review ; Risk factors ; Tomography</subject><ispartof>Theranostics, 2022-01, Vol.12 (4), p.1639-1658</ispartof><rights>The author(s).</rights><rights>2022. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The author(s) 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c406t-b9e174d7f7b46e7027ec226bc23e63c747ba12b4ca2e54671669fa87889e32bd3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825579/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825579/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35198062$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rajeev, Vismitha</creatorcontrib><creatorcontrib>Fann, David Y</creatorcontrib><creatorcontrib>Dinh, Quynh Nhu</creatorcontrib><creatorcontrib>Kim, Hyun Ah</creatorcontrib><creatorcontrib>De Silva, T Michael</creatorcontrib><creatorcontrib>Lai, Mitchell K P</creatorcontrib><creatorcontrib>Chen, Christopher Li-Hsian</creatorcontrib><creatorcontrib>Drummond, Grant R</creatorcontrib><creatorcontrib>Sobey, Christopher G</creatorcontrib><creatorcontrib>Arumugam, Thiruma V</creatorcontrib><title>Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment</title><title>Theranostics</title><addtitle>Theranostics</addtitle><description>The prevalence of cerebrovascular disease increases with age, placing the elderly at a greater lifetime risk for dementia. Vascular cognitive impairment (VCI) encompasses a spectrum of cognitive deficits from mild cognitive impairment to dementia. VCI and its most severe form, vascular dementia (VaD), is becoming a major public health concern worldwide. As growing efforts are being taken to understand VCI and VaD in animal models and humans, the pathogenesis of the disease is being actively explored. It is postulated that chronic cerebral hypoperfusion (CCH) is a major cause of VCI. CCH activates a molecular and cellular injury cascade that leads to breakdown of the blood brain barrier (BBB) and neurodegeneration. The BBB tightly regulates the movement of substances between the blood and the brain, thereby regulating the microenvironment within the brain parenchyma. Here we illustrate how BBB damage is causal in the pathogenesis of VCI through the increased activation of pathways related to excitotoxicity, oxidative stress, inflammation and matrix metalloproteinases that lead to downstream perivascular damage, leukocyte infiltration and white matter changes in the brain. Thus, CCH-induced BBB damage may initiate and contribute to a vicious cycle, resulting in progressive neuropathological changes of VCI in the brain. This review outlines the molecular and cellular mechanisms that govern BBB breakdown during CCH and highlights the clinical evidence in identifying at-risk VCI patients.</description><subject>Age</subject><subject>Aged</subject><subject>Alzheimer's disease</subject><subject>Animals</subject><subject>Blood vessels</subject><subject>Blood-brain barrier</subject><subject>Blood-Brain Barrier - metabolism</subject><subject>Brain - metabolism</subject><subject>Brain Ischemia - pathology</subject><subject>Cardiovascular disease</subject><subject>Cognitive ability</subject><subject>Cognitive Dysfunction - metabolism</subject><subject>Dementia</subject><subject>Dementia, Vascular - etiology</subject><subject>Dementia, Vascular - metabolism</subject><subject>Humans</subject><subject>Measurement techniques</subject><subject>Metabolism</subject><subject>Pathology</subject><subject>Pathophysiology</subject><subject>Permeability</subject><subject>Physiology</subject><subject>Review</subject><subject>Risk factors</subject><subject>Tomography</subject><issn>1838-7640</issn><issn>1838-7640</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkUtr3TAQhUVpaUKaTX9AEXRTCjfRy5K8KZTQFwSSRboWkjy-VrAlV7Iv-N9Xt0lDWm1GMN-cOcNB6C0lF4o25HIZYrqQmhPxAp1SzfVOSUFePvufoPNS7kl9grCWtq_RCW9oq4lkp2i7tcuQ5mErIY1pv-HUYzem1GGXbYjY2ZwDZNxtpV-jX0KKuFtziHvsh5xi8NhDhgqPeNjmNEPu13Kk6vDBFr-ONmOf9jEs4QA4TLMNeYK4vEGvejsWOH-sZ-jn1y93V9931zffflx9vt55QeSycy1QJTrVKyckKMIUeMak84yD5F4J5SxlTnjLoBFSUSnb3mqldQucuY6foU8PuvPqJuh8XV3NmjmHyebNJBvMv50YBrNPB6M1axrVVoEPjwI5_VqhLGYKxcM42ghpLYZJzjQRvFUVff8fep_WHOt5hilJtBS0oZX6-ED5nErJ0D-ZocQcQzXHUM2fUCv87rn9J_RvhPw3kV-hNg</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Rajeev, Vismitha</creator><creator>Fann, David Y</creator><creator>Dinh, Quynh Nhu</creator><creator>Kim, Hyun Ah</creator><creator>De Silva, T Michael</creator><creator>Lai, Mitchell K P</creator><creator>Chen, Christopher Li-Hsian</creator><creator>Drummond, Grant R</creator><creator>Sobey, Christopher G</creator><creator>Arumugam, Thiruma V</creator><general>Ivyspring International Publisher Pty Ltd</general><general>Ivyspring International Publisher</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220101</creationdate><title>Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment</title><author>Rajeev, Vismitha ; Fann, David Y ; Dinh, Quynh Nhu ; Kim, Hyun Ah ; De Silva, T Michael ; Lai, Mitchell K P ; Chen, Christopher Li-Hsian ; Drummond, Grant R ; Sobey, Christopher G ; Arumugam, Thiruma V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c406t-b9e174d7f7b46e7027ec226bc23e63c747ba12b4ca2e54671669fa87889e32bd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Age</topic><topic>Aged</topic><topic>Alzheimer's disease</topic><topic>Animals</topic><topic>Blood vessels</topic><topic>Blood-brain barrier</topic><topic>Blood-Brain Barrier - metabolism</topic><topic>Brain - metabolism</topic><topic>Brain Ischemia - pathology</topic><topic>Cardiovascular disease</topic><topic>Cognitive ability</topic><topic>Cognitive Dysfunction - metabolism</topic><topic>Dementia</topic><topic>Dementia, Vascular - etiology</topic><topic>Dementia, Vascular - metabolism</topic><topic>Humans</topic><topic>Measurement techniques</topic><topic>Metabolism</topic><topic>Pathology</topic><topic>Pathophysiology</topic><topic>Permeability</topic><topic>Physiology</topic><topic>Review</topic><topic>Risk factors</topic><topic>Tomography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rajeev, Vismitha</creatorcontrib><creatorcontrib>Fann, David Y</creatorcontrib><creatorcontrib>Dinh, Quynh Nhu</creatorcontrib><creatorcontrib>Kim, Hyun Ah</creatorcontrib><creatorcontrib>De Silva, T Michael</creatorcontrib><creatorcontrib>Lai, Mitchell K P</creatorcontrib><creatorcontrib>Chen, Christopher Li-Hsian</creatorcontrib><creatorcontrib>Drummond, Grant R</creatorcontrib><creatorcontrib>Sobey, Christopher G</creatorcontrib><creatorcontrib>Arumugam, Thiruma V</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Theranostics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rajeev, Vismitha</au><au>Fann, David Y</au><au>Dinh, Quynh Nhu</au><au>Kim, Hyun Ah</au><au>De Silva, T Michael</au><au>Lai, Mitchell K P</au><au>Chen, Christopher Li-Hsian</au><au>Drummond, Grant R</au><au>Sobey, Christopher G</au><au>Arumugam, Thiruma V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment</atitle><jtitle>Theranostics</jtitle><addtitle>Theranostics</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>12</volume><issue>4</issue><spage>1639</spage><epage>1658</epage><pages>1639-1658</pages><issn>1838-7640</issn><eissn>1838-7640</eissn><abstract>The prevalence of cerebrovascular disease increases with age, placing the elderly at a greater lifetime risk for dementia. Vascular cognitive impairment (VCI) encompasses a spectrum of cognitive deficits from mild cognitive impairment to dementia. VCI and its most severe form, vascular dementia (VaD), is becoming a major public health concern worldwide. As growing efforts are being taken to understand VCI and VaD in animal models and humans, the pathogenesis of the disease is being actively explored. It is postulated that chronic cerebral hypoperfusion (CCH) is a major cause of VCI. CCH activates a molecular and cellular injury cascade that leads to breakdown of the blood brain barrier (BBB) and neurodegeneration. The BBB tightly regulates the movement of substances between the blood and the brain, thereby regulating the microenvironment within the brain parenchyma. Here we illustrate how BBB damage is causal in the pathogenesis of VCI through the increased activation of pathways related to excitotoxicity, oxidative stress, inflammation and matrix metalloproteinases that lead to downstream perivascular damage, leukocyte infiltration and white matter changes in the brain. Thus, CCH-induced BBB damage may initiate and contribute to a vicious cycle, resulting in progressive neuropathological changes of VCI in the brain. This review outlines the molecular and cellular mechanisms that govern BBB breakdown during CCH and highlights the clinical evidence in identifying at-risk VCI patients.</abstract><cop>Australia</cop><pub>Ivyspring International Publisher Pty Ltd</pub><pmid>35198062</pmid><doi>10.7150/thno.68304</doi><tpages>20</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1838-7640
ispartof Theranostics, 2022-01, Vol.12 (4), p.1639-1658
issn 1838-7640
1838-7640
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8825579
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; PubMed Central
subjects Age
Aged
Alzheimer's disease
Animals
Blood vessels
Blood-brain barrier
Blood-Brain Barrier - metabolism
Brain - metabolism
Brain Ischemia - pathology
Cardiovascular disease
Cognitive ability
Cognitive Dysfunction - metabolism
Dementia
Dementia, Vascular - etiology
Dementia, Vascular - metabolism
Humans
Measurement techniques
Metabolism
Pathology
Pathophysiology
Permeability
Physiology
Review
Risk factors
Tomography
title Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T04%3A54%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pathophysiology%20of%20blood%20brain%20barrier%20dysfunction%20during%20chronic%20cerebral%20hypoperfusion%20in%20vascular%20cognitive%20impairment&rft.jtitle=Theranostics&rft.au=Rajeev,%20Vismitha&rft.date=2022-01-01&rft.volume=12&rft.issue=4&rft.spage=1639&rft.epage=1658&rft.pages=1639-1658&rft.issn=1838-7640&rft.eissn=1838-7640&rft_id=info:doi/10.7150/thno.68304&rft_dat=%3Cproquest_pubme%3E2632804397%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2760864151&rft_id=info:pmid/35198062&rfr_iscdi=true